Interstitial Cystitis
Phase 2
Completed
- Conditions
- Interstitial Cystitis
- First Posted Date
- 2003-03-10
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- ICOS Corporation
- Target Recruit Count
- 150
- Registration Number
- NCT00056251
- Locations
- ๐บ๐ธ
Georgia Urology, Atlanta, Georgia, United States
๐บ๐ธIntegrity Medical Research, LLC, Seattle, Washington, United States
๐บ๐ธAdvanced Research Institute, New Port Richey, Florida, United States
A Safety and Efficacy Study of Hospitalized Patients With Community-Acquired Pneumonia and Sepsis
Phase 2
Completed
- Conditions
- PneumoniaSepsis
- First Posted Date
- 2002-08-05
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- ICOS Corporation
- Registration Number
- NCT00042588
- Locations
- ๐บ๐ธ
ICOS Corporation, Bothell, Washington, United States
Safety and Efficacy of Recombinant Human Platelet-Activating Factor Acetylhydrolase for the Treatment of Severe Sepsis
Phase 3
Terminated
- Conditions
- Sepsis
- First Posted Date
- 2002-05-21
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- ICOS Corporation
- Target Recruit Count
- 2500
- Registration Number
- NCT00037687
- Locations
- ๐บ๐ธ
Mary E. Lonien, M.S., Bothell, Washington, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath